Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent developments in retroviral gene delivery systems.

P J Wysocki, P Grabarczyk, A Mackiewicz

    Expert Opinion on Biological Therapy
    |December 1, 2001
    PubMed
    Summary

    Retroviral vectors remain popular for gene therapy, but lentiviral vectors show superior performance. This review covers 2001 advancements in retroviral gene delivery systems.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Datopotamab deruxtecan (Dato-DXd) in combination with durvalumab as first-line treatment for unresectable locally advanced or metastatic triple-negative breast cancer: results from arms 7 and 8 of the phase Ib/II BEGONIA study.

    Annals of oncology : official journal of the European Society for Medical Oncology·2026
    Same author

    Prognostic impact of baseline tumour immune infiltrate on disease-free survival in patients with completely resected, BRAF<sup>v600</sup> mutation-positive melanoma receiving adjuvant vemurafenib.

    Annals of oncology : official journal of the European Society for Medical Oncology·2020
    Same author

    HCV viraemia associates with NK cell activation and dysfunction in antiretroviral therapy-treated HIV/HCV-co-infected subjects.

    Journal of viral hepatitis·2017
    Same author

    Comparative studies of cervical spine anterior stabilization systems--Finite element analysis.

    Clinical biomechanics (Bristol, Avon)·2016
    Same author

    Tumor suppressor TNFAIP3 (A20) is frequently deleted in Sézary syndrome.

    Leukemia·2011
    Same author

    Diagnostic evaluation of cancer antigens RAK .1. Cervical and ovarian cancer.

    International journal of oncology·2011

    Area of Science:

    • Molecular Biology
    • Virology
    • Biotechnology

    Background:

    • Retroviral vectors, including simple retroviruses like murine leukemia viruses (MLV), have been foundational in gene therapy since 1990.
    • Despite their prevalence (35% of trials), early retroviral vectors exhibit limitations such as low viral titer, transduction efficiency, and challenges in in vivo administration.

    Discussion:

    • Lentiviral vectors, a type of complex retrovirus, offer significant advantages over simple retroviruses.
    • Key improvements include high viral titers, stable transduction of non-dividing cells, and effective gene delivery to human progenitor cells (CD34+).

    Key Insights:

    • Lentiviral vectors represent a significant evolution in retroviral gene delivery technology.
    • The ability to transduce non-dividing cells and achieve high titers addresses critical limitations of earlier retroviral systems.

    Outlook:

    • The developments in 2001 highlight the ongoing refinement of retroviral vectors for enhanced gene therapy applications.
    • Continued research into lentiviral vectors is expected to further optimize gene delivery efficiency and safety.

    Related Experiment Videos